Member Info for Sangijuelas1

Tom, Angle go to about 10 conferences a year.

What do you believe is particularly meaningful about this one?

Not really. I still held some stock in a Sippy and on Freetrade and sold on the rise, so I was glad of it all things considered.

Thanks for the 10p PT though!

So you think it could drop back to 10p.

I thought you were supposed to be ramping. You're not very good, are you?

I also look to hold a stock long term. Hence the need for sustainable finances with no nasty shocks.

And then Bantham you get the "I can't sell at a loss- so I will wait for zero" rather than recovering funds and reinvesting elsewhere.

For me I need investments that pass the sustainability test in terms of solvency at least.

Also Bantham the posts lead to people who get caught up with the hype over extending themselves and ending up with a lot of cash on the table.

What should be a 5-10% max holding in an overall stock portfolio becomes a main holding.

Still, when this does happen there is always the Telegram Angle Support Group!

I would want to know that they aren't going to end up like 4D Pharma for a start!

It is very hard to really assess Parsortix against the multiple other techniques and technologies for CTC capture and enrichment.

It's a very crowded field with new developments all the time.

I like to hang out here because I know a lot about this stock from research etc. So I think my perspective is useful.

I have seen people burnt badly by listening to the likes of Rocket79. An old guy on 4D Pharma listened to the hype and now him and his wife are living on state pension as he went all in with his cashed in DB pension.

I warned people on SNG, TILS and a few others.

Also I am testing my thesis. If someone has an antithesis that convinced me to change my mind I would reconsider but I haven't heard anything yet.

Mr or Mrs Shorteverything

Maybe you could do everybody a favour and proof read your posts.

They are appalling. Really terrible errors of spelling and grammar.

Primary school kids living in deprived areas with brain damage can do better.

They are doing what they need to do to survive.

I don't want to invest where there is so much desperation.

Where does he state this?

They might speak to hospital doctors involved in research or clinical trials but it can't be used to make treatment decisions in hospitals.

As you say maybe in the future but not for at least 5-10 years when they have lab developed tests approved.

On your points

Revenue increased from about £1m to £2m. It was still under start of year projection.

Whilst it may be £6m -£8m this year if they do exceedingly well, there will have to be a raise. It seems that payments on the pharma services are staged so they take ages to register as income.

Cash runway is based on bootstrapping over the next 12 months. It is not a cause for celebration. The depressed SP has made a fundraise extremely unpalatable so they have had to put much of their work on hold, including, I reckon, the Solaris work.

Researchers have been using Parsortix for a number of years. They need to use it more. If it was as good as we think you would expect aggressive growth of the number of studies.

Berenberg are the house broker. An independent broker report would be necessary to be credible. Sadly analysts pay no attention to small caps, which is not Angle's fault.

The 250k from Eisai is indeed interesting. But it's a pilot with very limited certainty. So the jury is out.

As for the use of the word Breakthrough, Angle used the term on 3 RNS in the years 2017-19. The return on these previous "breakthroughs" currently stands at £2m. Not to mention the £100m or so that Angle has burnt through in the last few years.

Global have just increased their holding. Big deal.

I said I had considered buying at 20p but the Newland interview put me off.

All my posts are there for all to see

You seem to believe they can just add Parsortix to some cytology slides and start using it to monitor cancer cells.

That is the hope but in about 5-10 years after LDTs get approved and they have had to strip down operations to the bare minimum to survive.

I would guess that the reason the Solaris trial results are on ice is because they can't afford to proceed at this time.

People think they will be fine bootstrapping but I think the current PR push is because they need to get a fundraise in place.

No I considered buying but the Proactive interview put me off.

You haven't explained how doctors are going to use something that is currently only for research not clinical practice.

It's.For.Research.Use.Only.

If any of your predictions were any good then you wouldn't be on a platform like this as you would have already made so much money as to not need to waste your time.

Also if the stock was as good as you say then you would just keep quiet and accumulate more.

they seem different actually. all listed here

https://patents.justia.com/inventor/tomoyuki-sen

the diagrams seemed the same.

it's a shame you couldn't have said your goodbyes to the 4d crew on lse.

i was taking a lot of **** for trying to warn people about the loan covenants and now they are all in some kind of shareholder support group.

some terrible stories - one old guy ploughed his whole pension in.

They have options due to vest later this year for staff and directors.

So could also be that or pressure from IIs

If they weren't running on a shoestring I might be less skeptical. However, it all seems a bit do or die.

And the company seems to be engaged in a desperate effort to ramp the SP themselves. And you have to wonder why that is?